Wire · opportunities
Boston Scientific Discontinues Imager II Catheter. FDA Issues Early Alert Over Detachment Risk
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 31 August 2026 · Fusion42 review
Boston Scientific has discontinued its Imager II Catheter following an FDA early alert highlighting a risk of catheter detachment that could cause patient harm. The FDA's safety communication urges healthcare providers to consider alternative treatment options and report any adverse events related to the device.
This Wire brief sits within Fusion42's coverage of Medtech, and 3 sources have reported it between 28 Aug 2026 and 31 Aug 2026.
◆ ◆ The Wire takeaway
Medtech founders must act now to pivot from devices with flagged safety risks as the FDA's alerts turn patient safety into a market access barrier. Staying ahead on device stability issues will be critical for maintaining clinician trust and market share.
◆ Coverage
3 sources · first reported 28 Aug 2026 · latest 31 Aug 2026
◆ Related on Wire
◆ Topics